• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

存活素作为直肠癌放疗的放射抵抗因子及预后和治疗靶点。

Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.

作者信息

Rödel Franz, Hoffmann Jörg, Distel Luitpold, Herrmann Martin, Noisternig Timmo, Papadopoulos Thomas, Sauer Rolf, Rödel Claus

机构信息

Department of Radiation Oncology, Institutes of Clinical Immunology, and Pathology, University of Erlangen-Nuremberg, Erlangen, Germany.

出版信息

Cancer Res. 2005 Jun 1;65(11):4881-7. doi: 10.1158/0008-5472.CAN-04-3028.

DOI:10.1158/0008-5472.CAN-04-3028
PMID:15930309
Abstract

Apoptosis levels have been shown to predict tumor response to preoperative radiochemotherapy in rectal cancer. Recently, the prominent role of survivin, a structurally unique member of the inhibitor of apoptosis protein family, has been shown in colorectal cancer tumorigenesis and prognosis. In this study, we investigated whether survivin plays a direct role in mediating radiation resistance. We used short interfering RNA molecules to decrease survivin in radioresistant SW480 and intermediately radioresistant HCT-15 colorectal cancer cells. This resulted in a significant decrease of survivin mRNA and protein expression with a maximum at 24 to 48 hours after transfection. If irradiated during this sensitive period, an increased percentage of apoptotic cells and an increased caspase 3/7 activity in parallel with a decreased cell viability and a reduced clonogenic survival was shown. These effects were more pronounced in the radioresistant SW480 cell line with a radiation-induced cytotoxicity enhancement factor at 10% and 50% survival of 1.8 to 2.2 for SW480 and 1.5 to 1.7 for HCT-15, respectively. Furthermore, transfection with survivin short interfering RNA increased levels of G2-M arrest and levels of DNA double-strand breaks in irradiated cells. These observations indicate that cell cycle and DNA repair mechanisms may be associated with apoptosis induction in tumor cells that are otherwise resistant to killing by radiation. In a translational study of 59 patients with rectal cancer treated with a combination of radiotherapy and chemotherapy, increased survivin expression was inversely related to the levels of apoptosis, and was also associated with a significantly higher risk of a local tumor recurrence.

摘要

凋亡水平已被证明可预测直肠癌术前放化疗的肿瘤反应。最近,生存素作为凋亡抑制蛋白家族结构独特的成员,在结直肠癌的肿瘤发生和预后中发挥了重要作用。在本研究中,我们调查了生存素是否在介导放射抗性中起直接作用。我们使用短干扰RNA分子降低耐辐射的SW480和中度耐辐射的HCT-15结肠癌细胞中的生存素水平。这导致生存素mRNA和蛋白表达显著降低,在转染后24至48小时达到最大值。如果在这个敏感期进行照射,凋亡细胞百分比增加,半胱天冬酶3/7活性增加,同时细胞活力降低,克隆形成存活率降低。这些效应在耐辐射的SW480细胞系中更为明显,其辐射诱导的细胞毒性增强因子在10%和50%存活时,SW480分别为1.8至2.2,HCT-15为1.5至1.7。此外,用生存素短干扰RNA转染增加了受照射细胞中G2-M期阻滞水平和DNA双链断裂水平。这些观察结果表明,细胞周期和DNA修复机制可能与肿瘤细胞凋亡诱导有关,否则这些肿瘤细胞对辐射杀伤具有抗性。在一项对59例接受放疗和化疗联合治疗的直肠癌患者的转化研究中,生存素表达增加与凋亡水平呈负相关,并且也与局部肿瘤复发的显著更高风险相关。

相似文献

1
Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer.存活素作为直肠癌放疗的放射抵抗因子及预后和治疗靶点。
Cancer Res. 2005 Jun 1;65(11):4881-7. doi: 10.1158/0008-5472.CAN-04-3028.
2
Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.基因表达谱分析显示,生存素是3,3'-二吲哚甲烷诱导乳腺癌细胞生长抑制和凋亡的靶点。
Cancer Res. 2006 May 1;66(9):4952-60. doi: 10.1158/0008-5472.CAN-05-3918.
3
Downregulation of survivin by siRNA diminishes radioresistance of pancreatic cancer cells.小干扰RNA介导的生存素下调可降低胰腺癌细胞的放射抗性。
Surgery. 2005 Aug;138(2):299-305. doi: 10.1016/j.surg.2005.05.009.
4
Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.Survivin抑制可降低人子宫内膜癌的细胞增殖并诱导其凋亡。
Cancer. 2006 Aug 15;107(4):746-56. doi: 10.1002/cncr.22044.
5
Survivin downregulation by siRNA/cationic liposome complex radiosensitises human hepatoma cells in vitro and in vivo.Survivin 下调通过 siRNA/阳离子脂质体复合物在体外和体内增敏人肝癌细胞。
Int J Radiat Biol. 2010 Jun;86(6):445-57. doi: 10.3109/09553001003668006.
6
Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line.在对survivin小干扰RNA(siRNA)和放疗进行联合处理后,放射增敏作用与野生型p53肉瘤细胞系中半胱天冬酶3和7的激活相关,但在突变型p53肉瘤细胞系中则不然。
Oncol Rep. 2005 Jan;13(1):167-72.
7
siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.小干扰RNA介导的生存素下调抑制膀胱癌细胞生长。
Int J Oncol. 2004 Oct;25(4):1065-71.
8
Protective role of Hsp27 protein against gamma radiation-induced apoptosis and radiosensitization effects of Hsp27 gene silencing in different human tumor cells.Hsp27蛋白对γ射线诱导的细胞凋亡的保护作用以及Hsp27基因沉默在不同人类肿瘤细胞中的放射增敏作用。
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):543-53. doi: 10.1016/j.ijrobp.2007.08.061. Epub 2007 Nov 5.
9
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms.生存素通过不依赖半胱天冬酶的机制增强原发性人类胶质母细胞瘤细胞的抗辐射能力。
Oncogene. 2004 Sep 30;23(45):7494-506. doi: 10.1038/sj.onc.1208049.
10
Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.凋亡抑制蛋白存活素的破坏使Bcr-abl阳性细胞对STI571诱导的凋亡敏感。
Cancer Res. 2005 Sep 15;65(18):8224-32. doi: 10.1158/0008-5472.CAN-05-0303.

引用本文的文献

1
Cationic Metal-Organic Layer Delivers siRNAs to Overcome Radioresistance and Potentiate Cancer Radiotherapy.阳离子金属有机层递送小干扰RNA以克服放射抗性并增强癌症放射治疗效果。
Angew Chem Int Ed Engl. 2025 Feb 10;64(7):e202419409. doi: 10.1002/anie.202419409. Epub 2024 Nov 21.
2
Targeting mTOR and survivin concurrently potentiates radiation therapy in renal cell carcinoma by suppressing DNA damage repair and amplifying mitotic catastrophe.同时靶向 mTOR 和 survivin 通过抑制 DNA 损伤修复和放大有丝分裂灾难增强肾细胞癌的放射治疗效果。
J Exp Clin Cancer Res. 2024 Jun 6;43(1):159. doi: 10.1186/s13046-024-03079-8.
3
Survivin as a Therapeutic Target for the Treatment of Human Cancer.
生存素作为治疗人类癌症的治疗靶点。
Cancers (Basel). 2024 Apr 27;16(9):1705. doi: 10.3390/cancers16091705.
4
Targeting mTOR and Survivin Concurrently Potentiates Radiation Therapy in Renal Cell Carcinoma by Suppressing DNA Damage Repair and Amplifying Mitotic Catastrophe.同时靶向mTOR和Survivin通过抑制DNA损伤修复和放大有丝分裂灾难增强肾细胞癌的放射治疗效果。
Res Sq. 2023 Dec 23:rs.3.rs-3770403. doi: 10.21203/rs.3.rs-3770403/v1.
5
The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.水飞蓟素/水飞蓟宾在癌症放射增敏中的作用:系统评价。
Curr Med Chem. 2024;31(42):6992-7014. doi: 10.2174/0109298673248404231006052436.
6
Molecular mechanisms of tumor resistance to radiotherapy.肿瘤放疗抵抗的分子机制。
Mol Cancer. 2023 Jun 15;22(1):96. doi: 10.1186/s12943-023-01801-2.
7
The reversibility of cancer radioresistance: a novel potential way to identify factors contributing to tumor radioresistance.癌症放射抵抗的逆转:一种潜在的新方法,用于鉴定导致肿瘤放射抵抗的因素。
Hum Cell. 2023 May;36(3):963-971. doi: 10.1007/s13577-023-00871-0. Epub 2023 Feb 6.
8
New Nitric Oxide-Releasing Compounds as Promising Anti-Bladder Cancer Drugs.新型一氧化氮释放化合物有望成为抗膀胱癌药物。
Biomedicines. 2023 Jan 12;11(1):199. doi: 10.3390/biomedicines11010199.
9
Predictive value of a serum tumor biomarkers scoring system for clinical stage II/III rectal cancer with neoadjuvant chemoradiotherapy.血清肿瘤生物标志物评分系统对新辅助放化疗的临床II/III期直肠癌的预测价值
World J Gastrointest Oncol. 2022 Oct 15;14(10):2014-2024. doi: 10.4251/wjgo.v14.i10.2014.
10
Synthesis of novel 10,11-methylenedioxy-camptothecin glycoside derivatives and investigation of their anti-tumor effects .新型10,11-亚甲二氧基-喜树碱糖苷衍生物的合成及其抗肿瘤作用研究
RSC Adv. 2019 Apr 9;9(20):11142-11150. doi: 10.1039/c9ra00315k.